FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056564842> ?p ?o ?g. }

• W2056564842 endingPage "91" @default.
• W2056564842 startingPage "90" @default.
• W2056564842 abstract "In this issue of JAK-STAT, we introduce a series of reviews overlooking the ever-expanding field of myocardial JAK-STAT signaling. The history of cardiac JAK-STAT research begins in the mid-nineties, when various groups began to focus their attention on how myocardial physiology was specifically regulated through JAK-STAT signaling. Interest in the area began to grow following initial observations by the groups of Kishimoto and Chien, who were among the first to show that cardiac myocytes possess a functional gp130/JAK-STAT system that was intimately involved in the regulation of cardiac hypertrophy.1-3 Not long after, it was appreciated that STAT cardiac activity could be regulated by a host of diverse factors, including cardiotrophin-1, angiotensin II, leukemia inhibitory factor (LIF) and insulin, all of which suggested a that diverse and interesting underlying biology was at play.4-7 Several groups went on to characterize the activities and downstream effects of STAT1 and STAT3 in a host of cardiovascular pathologies.8 In an exciting series of discoveries for the field, the JAK-STAT pathway was found to play a fundamental role in the protective effects of both pre- and post- conditioning.9,10 The advent of cardiac-specific STAT-deficient mice further reinforced the essential requirement of STATs for normal myocardial functioning, an area in which the contributions of the late Helmut Drexler will be sorely missed.11,12 Recent discoveries such as the role of STATs in the development of cardiac stem cells and in controlling mitochondrial respiration have led to renewed enthusiasm in the field and set the stage for exciting times ahead in this area of cardiac research.13,14In this issue of JAK-STAT, some of the foremost experts in the field have come together to present the state of play in cardiovascular JAK-STAT biology. Frias et al. discuss recent exciting data showing that the sphingosine-1 phosphate (S1P) component of high density lipoproteins (HDL) exerts strong cardioprotective activity through the recently characterized survivor activating factor enhancement (SAFE) pathway.15 Booz and colleagues tackle the difficult question of trying to understand the many modes of STAT3 activity in the heart and examine the issue of differential signaling downstream of IL-6 family cytokines.16 Knight et al. review the recent findings that have uncovered how STAT1 and STAT3 regulate myocardial cell death during I/R injury, post-infarct remodeling and ischemic conditioning.17 Kishore and Verma discuss the cardioprotective actions of STAT3 and in particular the recent finding that IL-10, acting though STAT3, promotes increases survival of endothelial progenitor cells and vascularization of the heart.18 Fujio and colleagues discuss the timely topic of JAK-STAT signaling in cardiac stem cells with a focus on their recent work characterizing JAK-STAT mediated endothelial differentiation of Sca1+ cardiac progenitor cells through the kinase Pim-1.19 Finally, Wagner and Siddiqui focus on IL-6 trans-signaling, the intersection of the JAK-STAT and GPCR pathways and how components of the JAK-STAT pathway interact with the basal transcription machinery.20The story of myocardial JAK-STAT biology has led to intriguing and unexpected findings over the years and researchers continue to uncover novel ways in which the JAK-STAT pathway controls cardiac health, homeostasis and pathology. We must also be mindful that along with significant advances in basic research, there is still a great unmet need for new therapies in cardiovascular disease. As we look to the future, the onus is on us all to expand upon the significant understanding we have gained in how the JAK-STAT pathway influences cardiac biology and use it as a platform to improve human cardiovascular health.About Dr Sean BarryDr Barry received his PhD from University College London under the supervision of Prof. David Latchman and Dr Anastasis Stephanou. There he studied the role of STAT transcription factors in regulating cell fate following ischemic ..." @default.
• W2056564842 created "2016-06-24" @default.
• W2056564842 creator A5080763334 @default.
• W2056564842 date "2012-04-01" @default.
• W2056564842 modified "2023-09-24" @default.
• W2056564842 title "JAK-STAT" @default.
• W2056564842 cites W1492344672 @default.
• W2056564842 cites W1982477861 @default.
• W2056564842 cites W1991447679 @default.
• W2056564842 cites W1991838517 @default.
• W2056564842 cites W1992738986 @default.
• W2056564842 cites W1997282845 @default.
• W2056564842 cites W2004549688 @default.
• W2056564842 cites W2006312889 @default.
• W2056564842 cites W2013085806 @default.
• W2056564842 cites W2022123949 @default.
• W2056564842 cites W2023985916 @default.
• W2056564842 cites W2033862525 @default.
• W2056564842 cites W2042503285 @default.
• W2056564842 cites W2050734563 @default.
• W2056564842 cites W2059520509 @default.
• W2056564842 cites W2066436387 @default.
• W2056564842 cites W2087940624 @default.
• W2056564842 cites W2113162775 @default.
• W2056564842 cites W2134718106 @default.
• W2056564842 cites W2161156615 @default.
• W2056564842 doi "https://doi.org/10.4161/jkst.20939" @default.
• W2056564842 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3670300" @default.
• W2056564842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24058757" @default.
• W2056564842 hasPublicationYear "2012" @default.
• W2056564842 type Work @default.
• W2056564842 sameAs 2056564842 @default.
• W2056564842 citedByCount "0" @default.
• W2056564842 crossrefType "journal-article" @default.
• W2056564842 hasAuthorship W2056564842A5080763334 @default.
• W2056564842 hasBestOaLocation W20565648421 @default.
• W2056564842 hasConcept C2778277574 @default.
• W2056564842 hasConcept C2778923194 @default.
• W2056564842 hasConcept C41008148 @default.
• W2056564842 hasConcept C62478195 @default.
• W2056564842 hasConcept C86803240 @default.
• W2056564842 hasConcept C95444343 @default.
• W2056564842 hasConceptScore W2056564842C2778277574 @default.
• W2056564842 hasConceptScore W2056564842C2778923194 @default.
• W2056564842 hasConceptScore W2056564842C41008148 @default.
• W2056564842 hasConceptScore W2056564842C62478195 @default.
• W2056564842 hasConceptScore W2056564842C86803240 @default.
• W2056564842 hasConceptScore W2056564842C95444343 @default.
• W2056564842 hasIssue "2" @default.
• W2056564842 hasLocation W20565648421 @default.
• W2056564842 hasLocation W20565648422 @default.
• W2056564842 hasLocation W20565648423 @default.
• W2056564842 hasLocation W20565648424 @default.
• W2056564842 hasOpenAccess W2056564842 @default.
• W2056564842 hasPrimaryLocation W20565648421 @default.
• W2056564842 hasRelatedWork W2031573372 @default.
• W2056564842 hasRelatedWork W2358668433 @default.
• W2056564842 hasRelatedWork W2371121925 @default.
• W2056564842 hasRelatedWork W2376932109 @default.
• W2056564842 hasRelatedWork W2390279801 @default.
• W2056564842 hasRelatedWork W2748952813 @default.
• W2056564842 hasRelatedWork W2899084033 @default.
• W2056564842 hasRelatedWork W2956485728 @default.
• W2056564842 hasRelatedWork W3030430770 @default.
• W2056564842 hasRelatedWork W4239766474 @default.
• W2056564842 hasVolume "1" @default.
• W2056564842 isParatext "false" @default.
• W2056564842 isRetracted "false" @default.
• W2056564842 magId "2056564842" @default.
• W2056564842 workType "article" @default.